Kevin Baszis

Medicine & Life Sciences

1. Juvenile Arthritis 100%
2. Rheumatology 61%
3. Vasculitis 56%
4. Pediatrics 50%
5. Dermatomyositis 42%
6. Child 41%
7. Registries 40%
8. Calcinosis 34%
9. Granulomatosis with Polyangiitis 29%
10. Arthritis 27%
11. Systemic Lupus Erythematosus 24%
12. Rheumatologists 22%
13. Microscopic Polyangiitis 22%
14. Juvenile-onset scleroderma 21%
15. 2,6-dinitrotoluene 20%
16. Schoenlein-Henoch Purpura 17%
17. Scurvy 17%
18. Therapeutics 17%
19. Antineutrophil Cytoplasmic Antibodies 17%
20. Parotitis 17%
21. Steroids 17%
22. Catatonia 16%
23. Localized Scleroderma 16%
24. Mobility Limitation 15%
25. Myxoma 14%
26. Cardiac Tamponade 14%
27. Electroconvulsive Therapy 14%
28. Azathioprine 13%
29. Tumor Necrosis Factor-alpha 12%
30. Glucocorticoids 12%
31. Inflammatory Bowel Diseases 11%
32. Autoimmunity 11%
33. Tumor Necrosis Factor Inhibitors 11%
34. Consensus 11%
35. Exanthema 10%
36. Lung Diseases 10%
37. Intravenous Immunoglobulins 10%
38. Inflammation 10%
39. Adrenal Cortex Hormones 9%
40. Parturition 8%
41. Cohort Studies 7%
42. Phenotype 7%
43. Physicians 7%
44. Heart 7%
45. T-Lymphocytes 7%
46. Mucocutaneous Lymph Node Syndrome 7%
47. Rituximab 6%
48. Methylprednisolone 6%
49. Duration of Therapy 6%
50. Neonatal Systemic lupus erythematosus 6%